CDH11 and metastatic malignant neoplasm: To demonstrate the transcriptional silencing of CDH11 in metastatic cancer cells in association with the presence of CpG island hypermethylation, we measured CDH11 mRNA and protein levels by quantitative RT–PCR (qRT–PCR) (Figure 2B) and western blot (Figure 2C), respectively.